FIELD: medicine.
SUBSTANCE: present invention relates to pharmaceutics and a tablet with high drug content, which contains an active component in form of a formula (I) 
compound or its pharmaceutically acceptable salt in amount of approximately 30-80 wt % of active component, in total mass of the tablet and at least one binding substance, which contains microcrystalline cellulose or hydroxypropylmethicellulose.
EFFECT: design of a tablet with high drug content.
16 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TABLET WITH HIGH CONTENT OF MEDICATION | 2009 |
|
RU2405540C1 |
| DISPERSED TABLETS DEFERASIROKS | 2003 |
|
RU2338532C2 |
| NEW COMPOSITION | 2006 |
|
RU2821230C2 |
| NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
| HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
| GALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2009 |
|
RU2438661C2 |
| SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF VILDAGLIPTIN AND GLIQUIDONE | 2014 |
|
RU2585378C1 |
| ORAL SOLID DOSAGE FORM AND METHOD OF TREATING | 2011 |
|
RU2480210C1 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
